MR Imaging Biomarkers in Amyotrophic Lateral Sclerosis
- 16 August 2017
- journal article
- editorial
- Published by Elsevier BV in Academic Radiology
- Vol. 24 (10), 1185-1186
- https://doi.org/10.1016/j.acra.2017.07.004
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trialThe Lancet Neurology, 2017
- The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic reviewBMC Neurology, 2016
- Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changesThe Lancet Neurology, 2014
- Neuroimaging in Amyotrophic Lateral SclerosisNeurotherapeutics, 2011
- ALS motor phenotype heterogeneity, focality, and spreadNeurology, 2009
- How common are the “common” neurologic disorders?Neurology, 2007
- Amyotrophic Lateral Sclerosis: Diffusion-Tensor and Chemical Shift MR Imaging at 3.0 TRadiology, 2006
- Amyotrophic Lateral SclerosisThe New England Journal of Medicine, 2001
- MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted imagesJournal of the Neurological Sciences, 2001
- Diagnosis of amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1998